Meta-analysis of the association between new hypoglycemic agents and digestive diseases
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference35 articles.
1. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.;Zelniker;Lancet,2019
2. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis.;Neuen;Lancet Diabetes Endocrinol,2019
3. Effects of SGLT2 inhibitors on cardiovascular and renal outcomes in type 2 diabetes: a meta-analysis with trial sequential analysis.;Qiu;Medicine (Baltimore),2021
4. Meta-analysis on the safety and cardiorenal efficacy of SGLT2 inhibitors in patients without T2DM.;Li;Front Cardiovasc Med,2021
5. Appraisal of non-cardiovascular safety for sodium-glucose co-transporter 2 inhibitors: a systematic review and meta-analysis of placebo-controlled randomized clinical trials.;Shi;Front Pharmacol,2019
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring the mortality and cardiovascular outcomes with SGLT-2 inhibitors in patients with T2DM at dialysis commencement: a health global federated network analysis;Cardiovascular Diabetology;2024-09-03
2. Incretin mimetics and acute pancreatitis: enemy or innocent bystander?;Current Opinion in Gastroenterology;2024-07-04
3. Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for new-onset gastric cancer and gastric diseases in patients with type 2 diabetes mellitus: a population-based cohort study;Gastric Cancer;2024-06-10
4. A comprehensive meta-analysis on the association of SGLT2is and GLP-1RAs with vascular diseases, digestive diseases and fractures;Acta Diabetologica;2024-05-07
5. The effect of incretin-based drugs on the riks of acute pancreatitis: a review;Journal of Diabetes & Metabolic Disorders;2024-05-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3